Diane Gajewczyk

Diane Gajewczyk has extensive experience in the pharmaceutical industry. Diane started their career at Biovail in 2002, where they held various roles in scientific and medical affairs, including Director and Legacy Business Unit Head. Diane then worked at InterMune as the Director of Medical Affairs before joining Eisai as a Medical Director. Diane's next role was at Galderma, where they served as the Senior Director of Medical Affairs. Currently, they are the Vice President of Scientific and Medical Affairs at Cipher Pharmaceuticals Inc.

Diane Gajewczyk holds a PhD in Microbiology and Immunology from the University of Toronto. Diane also completed an Executive MBA with a focus on Business at the Ivey Business School at Western University. Diane obtained a Bachelor of Science (B.Sc.) in Medical Microbiology & Immunology from the University of Toronto - University of St. Michael's College. In 2022, they pursued studies in Artificial Intelligence at the Harvard T.H. Chan School of Public Health, specializing in the application of AI in Healthcare. Diane also obtained a certification in Applied AI in Healthcare from the same institution in May 2022.